Protein Kinase C β Inhibitor LY333531 Attenuates Intercellular Adhesion Molecule-1 and Monocyte Chemotactic Protein-1 Expression in the Kidney in Diabetic Rats-Reference-Cited by-同舟云学术

Protein Kinase C β Inhibitor LY333531 Attenuates Intercellular Adhesion Molecule-1 and Monocyte Chemotactic Protein-1 Expression in the Kidney in Diabetic Rats

Published:2006 Issue:4 Volume:101 Page:335-343
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:J Pharmacol Sci

Author:

Wu Yonggui,Wu Guozhong,Qi Xiangming,Lin Hui,Qian Hao,Shen Jijia,Lin Shantan

Publisher

Japanese Pharmacological Society

Subject

Pharmacology,Molecular Medicine

Reference43 articles.

1. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes

2. 2 Phillips AO, Baboolal K, Riley S, Grone H, Janssen U, Steadman R, et al. Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the Goto Kakizaki model of non-insulin dependent diabetes mellitus. Am J Kidney Dis. 2001;37:400–410.

3. 3 Sassy-Prigent C, Heudes D, Mandet C, Belair MF, Michel O, Perdereau B, et al. Early glomerular macrophage recruitment in streptozotocin- induced diabetic rats. Diabetes. 2000;49:466–475.

4. Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury

5. 5 Nathan CF. Secretory products of macrophages. J Clin Invest. 1987;79:319–326.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PKCδ regulates the vascular biology in diabetic atherosclerosis;Cell Communication and Signaling;2023-11-16

2. Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms;Frontiers in Endocrinology;2023-10-04

3. A Strategic Investigation on Diabetic Nephropathy; Its Conceptual Model and clinical Manifestations: A Review;Current Diabetes Reviews;2023-06

4. SGLT2 Inhibitor—Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism;Pharmaceutics;2023-03-16

5. The Mechanistic Role of Different Mediators in the Pathophysiology of Nephropathy: A Review;Current Drug Targets;2023-02